2 197

Cited 0 times in

주의력결핍 과잉행동장애에서 오로스 메칠페니데이트의 효용성

Other Titles
 Efficacy of OROS Methylphenidate for the Treatment of ADHD 
Authors
 송정은  ;  김봉석  ;  손정우  ;  유한익  ;  이소영  ;  한덕현  ;  송동호 
Citation
 JOURNAL OF THE KOREAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, Vol.23(부록) : 12-23, 2013 
Journal Title
 JOURNAL OF THE KOREAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY 
ISSN
 1225-729X 
Issue Date
2013
Keywords
Attention-Deficit/Hyperactivity Disorder ; OROS methylphenidate ; Efficacy
Abstract
Attention-deficit/hyperactivity disorder (ADHD) is one of the common psychiatric problems in childhood. The symptoms of ADHD tend to last for adulthood and the patients suffer from various comorbid problems and functional impairments. Methylphenidate (MPH) is the first choice of pharmacotherapy for ADHD and many researches have demonstrated its efficacy. We reviewed the clinical trials for efficacy of MPH focusing on Osmotic-Controlled Release Oral delivery System Methylphenidate (OROS MPH). It was identified that MPH improved core symptom of ADHD, peer relationship and health related quality of life and might improve various aspects of cognitive function. It was proved that the efficacy of OROS MPH was better than placebo and comparable to immediate release MPH (IR MPH) dosed three times daily in various studies. Especially, parent's preference of OROS MPH was better than IR MPH. The efficacy of MPH for academic achievement was equivocal. Long-term efficacy of OROS MPH was also inconclusive and further study is necessary.
Full Text
http://www.dbpia.co.kr/Journal/ArticleDetail/3039952
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Psychiatry (정신과학교실) > 1. Journal Papers
Yonsei Authors
Song, Dong Ho(송동호) ORCID logo https://orcid.org/0000-0002-9647-3130
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/88969
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse